undefined Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Medical Devices & Instruments
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Performance
Despite a slight dip in gross margin, TELA Bio Inc (TELA) reports a robust 26% revenue increase and successful public equity offering, enhancing its financial outlook. 3 days ago
Biotechnology
Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and Advancing CNS Treatments
Despite a decrease in cash reserves, Relmada Therapeutics Inc (RLMD) remains focused on pivotal CNS disorder studies with key milestones anticipated by year-end. 3 days ago
Medical Devices & Instruments
Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Despite a net loss, Accelerate Diagnostics Inc (AXDX) reports significant improvements in gross margin and strategic progress in clinical trials and product approvals. 3 days ago
Oil & Gas
SandRidge Energy Inc (SDRPQ.PFD) Q3 2024 Earnings Call Highlights: Strategic Acquisitions and Strong Financial Performance Amidst Market Challenges
Despite low natural gas prices, SandRidge Energy Inc (SDRPQ.PFD) boosts production and cash flow through strategic acquisitions and maintains a debt-free position. 3 days ago